Susquehanna Portfolio Strategies’s Stoke Therapeutics STOK Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.88M	Sell	119,226 -7,124	-6%	-$234K	0.06%	347
2025 Q4	$4.01M	Hold	126,350	–	–	0.06%	345
2025 Q3	$2.97M	Hold	126,350	–	–	0.05%	420
2025 Q2	$1.43M	Buy	126,350 +111,600	+757%	+$1.06M	0.03%	443
2025 Q1	$98.1K	Buy	+14,750	New	+$138K	0.04%	147
2024 Q3	–	Sell	-43,424	Closed	-$587K	–	478
2024 Q2	$587K	Hold	43,424	–	–	0.02%	344
2024 Q1	$586K	Sell	43,424 -1,684	-4%	-$10.2K	0.01%	560
2023 Q4	$237K	Buy	+45,108	New	+$193K	﹤0.01%	907

Other funds holding STOK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Susquehanna Portfolio Strategies's STOK Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Stoke Therapeutics (STOK) stake by 5.6% in Q1 2026, selling an estimated $234K and leaving 119,226 shares worth $3.88M. The position accounts for 0.06% of the portfolio, ranked #347.

Susquehanna Portfolio Strategies first reported a position in STOK in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.01M in Q4 2025. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

Susquehanna Portfolio Strategies held 119,226 shares of Stoke Therapeutics worth $3.88M as of Q1 2026.
Susquehanna Portfolio Strategies sold 7,124 Stoke Therapeutics shares in Q1 2026, an estimated $234K.
Stoke Therapeutics made up 0.06% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #347 holding.
Susquehanna Portfolio Strategies first reported a position in Stoke Therapeutics in Q4 2023 and has held it in 8 quarters since.
Susquehanna Portfolio Strategies's Stoke Therapeutics position peaked at $4.01M in Q4 2025.
196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.